There have been no discussions between the Secretary of State for Transport and the Chancellor of the Exchequer on that particular subject. Many employers already offer loans for season tickets or salary sacrifice schemes, and the Department has recently published revised guidance on cycle to work schemes and other ways in which employers can encourage people to cycle to work. The Government has also ensured that regulated rail fares can rise by no more than inflation since 2014.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3996", "label" : {"_value" : "Biography information for Andrew Jones"} } , "answeringMemberConstituency" : {"_value" : "Harrogate and Knaresborough"} , "answeringMemberPrinted" : {"_value" : "Andrew Jones"} , "dateOfAnswer" : {"_value" : "2019-07-16", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-07-16T14:49:56.31Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "27"} , "answeringDeptShortName" : {"_value" : "Transport"} , "answeringDeptSortName" : {"_value" : "Transport"} , "date" : {"_value" : "2019-07-08", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Public Transport: Voucher Schemes"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Transport, whether he has had discussions with the Chancellor of the Exchequer on establishing a public transport voucher scheme to allow vouchers to be taken from wages pre-taxation to encourage people to use public transport and lower carbon emissions in cities.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"} } , "tablingMemberConstituency" : {"_value" : "Strangford"} , "tablingMemberPrinted" : [{"_value" : "Jim Shannon"} ], "uin" : "274537"} , {"_about" : "http://data.parliament.uk/resources/1137414", "AnsweringBody" : [{"_value" : "Department for Education"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1137414/answer", "answerText" : {"_value" : "
The Government is committed to increasing gender equality in science, technology, engineering and mathematics (STEM) subjects. Efforts have been made to ensure that girls and boys can succeed on an equal basis particularly in STEM. Data from the Joint Council for Qualifications shows that entries by girls made up 27.2% of all entries to A levels in STEM subjects in 2018, an increase of 6.4 percentage points since 2010. There is near gender parity in most STEM subjects at GCSE with entries by girls making up 50% of those sitting biology, physics and chemistry GCSEs respectively in 2018.<\/p>
<\/p>
The Department is funding a £2.4 million program to improve girls\u2019 participation in computer science. The Department also funds the Stimulating Physics Network to improve progression to A level physics with a particular focus on improving girls\u2019 participation.<\/p>
<\/p>
The Department has committed to improving STEM careers advice in schools in the Careers Strategy. This includes ensuring that STEM engagement, such as with employers and apprenticeships, are built into school career programmes by updating school and college statutory guidance. The Department is also raising awareness of the range of careers that STEM qualifications offer through programmes such as STEM ambassadors, 44% of which ambassadors are women.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/111", "label" : {"_value" : "Biography information for Nick Gibb"} } , "answeringMemberConstituency" : {"_value" : "Bognor Regis and Littlehampton"} , "answeringMemberPrinted" : {"_value" : "Nick Gibb"} , "dateOfAnswer" : {"_value" : "2019-07-16", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-07-16T16:33:03.433Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "60"} , "answeringDeptShortName" : {"_value" : "Education"} , "answeringDeptSortName" : {"_value" : "Education"} , "date" : {"_value" : "2019-07-08", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "STEM Subjects: Equality"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Education, what steps he is taking with the Secretary of State for Education to increase gender equality in STEM subjects.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"} } , "tablingMemberConstituency" : {"_value" : "Strangford"} , "tablingMemberPrinted" : [{"_value" : "Jim Shannon"} ], "uin" : "274538"} , {"_about" : "http://data.parliament.uk/resources/1137417", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1137417/answer", "answerText" : {"_value" : "
The Accelerated Access Collaborative (AAC) is interested in identifying and supporting strategically important products that will have the biggest impact on patient health outcomes and/or the delivery of National Health Service services. This may include those which help control hospital-acquired infections.<\/p>
The AAC has already had made significant progress towards getting the best innovations to patients quicker and at a better cost for the NHS.<\/p>
Since 2018, NHS England has been supporting SecurAcath and Plus Sutures, products designed to reduce infection rates, on the Innovation and Technology Payment programme. SecurAcath is a device to secure catheters that reduces the infection risk for patients with a peripherally inserted central catheter and has benefited over 80,000 patients. Seven trusts with higher than 4% surgical site infection rates have adopted Plus Sutures, a triclosan coated suture, with more trusts to be supported this year.<\/p>
<\/p>
<\/strong><\/p> <\/strong><\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4008", "label" : {"_value" : "Biography information for Dame Caroline Dinenage"}
}
, "answeringMemberConstituency" : {"_value" : "Gosport"}
, "answeringMemberPrinted" : {"_value" : "Caroline Dinenage"}
, "dateOfAnswer" : {"_value" : "2019-07-15", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-07-15T15:26:22.27Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-07-08", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Hospitals: Infectious Diseases"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what plans the Accelerated Access Collaborative has to prioritise products which help to control hospital-acquired infections.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"}
}
, "tablingMemberConstituency" : {"_value" : "Strangford"}
, "tablingMemberPrinted" : [{"_value" : "Jim Shannon"}
], "uin" : "274541"}
, {"_about" : "http://data.parliament.uk/resources/1137418", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1137418/answer", "answerText" : {"_value" : " The Accelerated Access Collaborative (AAC) is interested in supporting the most strategically important products that will have the biggest impact on patient health outcomes and delivery of National Health Service services.<\/p> When selecting products, the AAC will consider the following irrespective of innovation type (i.e. medicines, diagnostic tools, and digital products):<\/p> - evidence of clinical and cost effectiveness;<\/p> - addressing significant unmet need;<\/p> - application to large populations or high budget impact; and<\/p> - enabling a novel mode of action or enabling significant changes to the care pathway.<\/p> Further information is available at the following link:<\/p>